139 related articles for article (PubMed ID: 31583003)
1. An Immunohistochemical Study of Cyclin D1 Expression in Astrocytic Tumors and its Correlation with Tumor Grade.
Mahzouni P; Taheri F
Iran J Pathol; 2019; 14(3):252-257. PubMed ID: 31583003
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclin D1 in glial tumors-A retrospective and observational study.
Mehta R; Yadav R; Vatsgotra R
Indian J Pathol Microbiol; 2023; 66(2):264-268. PubMed ID: 37077066
[TBL] [Abstract][Full Text] [Related]
3. Clinical Correlation and Role of Cyclin D1 Expression in Glioblastoma Patients: A Study From North India.
Jaiswal M; Tripathi A; Singh D; Kumar A; Singh M; Batra N; Verma A
Cureus; 2022 Feb; 14(2):e22346. PubMed ID: 35223330
[TBL] [Abstract][Full Text] [Related]
4. [Expression of cyclin D1 in brain gliomas and its significance].
Tan PG; Xing Z; Li ZQ
Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 in astrocytic tumours: an immunohistochemical study.
Chakrabarty A; Bridges LR; Gray S
Neuropathol Appl Neurobiol; 1996 Aug; 22(4):311-6. PubMed ID: 8875465
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of cyclin D1 in renal cell carcinoma.
Lima MS; Pereira RA; Costa RS; Tucci S; Dantas M; Muglia VF; Ravinal RC; Barros-Silva GE
Int Urol Nephrol; 2014 May; 46(5):905-13. PubMed ID: 24242739
[TBL] [Abstract][Full Text] [Related]
9. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system.
Ren Y; Munyer P; Kepes JJ; Cansler M; Collins J; Gayed B; Tawfik O
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):14-8. PubMed ID: 11277408
[TBL] [Abstract][Full Text] [Related]
11. Beta-catenin and cyclin D1 in mucoepidermoid carcinoma of variable histologic grades.
Miguel MC; Oliveira MC; Seabra FR; Queiroz LM; Freitas Rde A; Batista de Souza L
Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):701-6. PubMed ID: 16103302
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
[TBL] [Abstract][Full Text] [Related]
13. Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations.
Liu C; Tu Y; Sun X; Jiang J; Jin X; Bo X; Li Z; Bian A; Wang X; Liu D; Wang Z; Ding L
Clin Exp Med; 2011 Jun; 11(2):105-12. PubMed ID: 20809334
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters.
Ravikumar G; Ananthamurthy A
J Cancer Res Ther; 2014; 10(3):671-5. PubMed ID: 25313758
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of nucleostemin expression and its correlation with cyclin D1 expression in malignant ovarian tumors.
Lin S; Yu HS
Int J Gynecol Cancer; 2011 Oct; 21(7):1166-71. PubMed ID: 21892090
[TBL] [Abstract][Full Text] [Related]
16. Increased signal transducer and activator of transcription 3 (STAT3) and decreased cyclin D1 in recurrent astrocytic tumours compared with paired primary astrocytic tumours.
Zhang K; Pang B; Xin T; Hou X; Jia J; Feng B; Meng L; Xu S; Pang Q
J Int Med Res; 2011; 39(6):2103-9. PubMed ID: 22289525
[TBL] [Abstract][Full Text] [Related]
17. Expression of G1/S Phase Checkpoint Proteins in Breast Carcinoma: Relationship to Clinicopathologic Factors andSurvival Rate.
Lee MJ
Cancer Res Treat; 2002 Aug; 34(4):268-73. PubMed ID: 26680874
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
19. High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma.
Zhang C; Zhang P; Hao J; Quddus MR; Steinhoff MM; Sung CJ
Breast J; 2005; 11(1):2-8. PubMed ID: 15647071
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in prostate carcinoma.
Pereira RA; Ravinal RC; Costa RS; Lima MS; Tucci S; Muglia VF; Reis RB; Silva GE
Braz J Med Biol Res; 2014 Jun; 47(6):515-21. PubMed ID: 24820071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
